AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
AbCellera announced a proposed $200.0 million public offering of common stock and pre-funded warrants to support its clinical pipeline. Net proceeds are intended to fund the research, development, and clinical advancement of its internal pipeline, including lead program ABCL635, as well as for working capital. Jefferies, J.P.
Key figures
- Deal Value Usd
- $200.0 million
- Lead program
- ABCL635
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.